Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322)
EMD Serono
EMD Serono
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Nimbus Therapeutics
Actuate Therapeutics Inc.
Pfizer
EMD Serono
Seagen Inc.
Emory University